|
| |
BRAF
| Symbol: | BRAF | | Name(s): | v-raf murine sarcoma viral oncogene homolog B1 | | Type: | protein-coding | | Organism: | Homo sapiens | | Synonyms: | B-raf 1, BRAF1, MGC126806, MGC138284, RAFB1 | | Links: |
Pubmed,
Entrez Gene,
GeneCards,
BioGPS,
Map Viewer.
|
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 18224685 |
Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator) |
| 18199160 |
A worse clinical outcome was found for CIMP-high, microsatellite stable colorectal cancer with KRAS/BRAF mutation but not for those lacking KRAS/BRAF mutation. |
| 17940185 |
BRAF mutation represents a novel indicator of the progression and aggressiveness of papillary thyroid cancer (Review) |
| 18098337 |
BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations. |
| 14722037 |
Observational study of genotype prevalence and gene-disease association. (HuGE Navigator) |
| 15824163 |
Observational study of gene-disease association. (HuGE Navigator) |
| 15904951 |
Observational study of gene-disease association. (HuGE Navigator) |
| 15968271 |
Observational study of gene-disease association. (HuGE Navigator) |
| 15994075 |
Observational study of gene-disease association. (HuGE Navigator) |
| 16015629 |
Observational study of gene-disease association. (HuGE Navigator) | →View more information from publications. |
Press Releases on BRAF:
|
 |
| MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009 |
24th June, 2009 |
The Arcas Group |
ATLANTA, June 24 /PRNewswire/ -- MDOUTLOOK(R), the innovative oncology intelligence platform, today announced the results from its Quick Poll research, which was launched immediately following
|
| Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations |
22nd June, 2009 |
Exosome Diagnostics, Inc. |
NEW YORK, June 22 /PRNewswire/ -- Exosome Diagnostics, Inc. ("ExosomeDX") and DxS Ltd. ("DxS") today announced that they will collaborate on the development of blood-based
|
| Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS, NRAS, and BRAF Gene Mutations in Reflex Testing Service |
1st June, 2009 |
Quest Diagnostics Incorporated |
EGFR Pathway Test analyzes in sequential reflex fashion more mutations potentially inhibiting anti-EGFR therapy response in metastatic colorectal cancer patients
MADISON, N
|
| Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day |
24th April, 2009 |
Micromet, Inc. |
Pivotal Trial Expected to Initiate in 2010 for Blinatumomab
NEW YORK, April 24 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company
|
| Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells |
22nd April, 2009 |
Micromet, Inc. |
Study Presented at 2009 AACR Meeting Highlights Potential Therapeutic Approach to Treat Patients Unresponsive to Erbitux and Vectibix
DENVER, April 22 /PRNewswire-FirstCall/
|
BRAF results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for BRAF,
or search for BRAF on BioPortfolio's antibody search engine.
This page has been viewed 579 times
Recent Search Terms used to find this page: B raf synonyms | braf kras esmo 2009 | skin cancer and braf protein | BRAF AND muscle | braf 2009 | meetings exosome 2010 | B-Raf L12G7 BRAF mutation | BRAF synonyms | Papillary microcarcimoma in comparison with larger papillary thyroid carcinoma in BRAF V600E mutation clinicopathological features and immunohistochemical findings. | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
